MURA – mural oncology plc - ordinary shares (US:NASDAQ)

News

Mural Oncology Announces Sanction of the Scheme by the High Court
Mural Oncology (NASDAQ:MURA) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
Mural Oncology Announces Final Cash Consideration Payable on Closing of Acquisition by XOMA Royalty
Mural Oncology (NASDAQ:MURA) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
Form 8.3 [Yahoo! Finance]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com